Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ridaura Tiltab 3mg tablets
1001030A0BBAAAA
|
Ridaura | Auranofin | Musculoskeletal and Joint Diseases | No data available |
|
Riddell Minor inhaler
21010220102
|
Riddell Minor inhaler | Other Appliances | Appliances | No data available |
|
Riddopag Pocket inhaler
21010220104
|
Riddopag Pocket inhaler | Other Appliances | Appliances | No data available |
|
Rideril 100mg tablets
0402010W0BCABAH
|
Rideril | Thioridazine | Central Nervous System | No data available |
|
Rideril 25mg tablets
0402010W0BCAAAF
|
Rideril | Thioridazine | Central Nervous System | No data available |
|
Rideril 50mg tablets
0402010W0BCACAG
|
Rideril | Thioridazine | Central Nervous System | No data available |
|
Riemann P20 Once a Day sunfilter lotion SPF 15
130801000BBDYA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Riemann P20 spray SPF 15
130801000BBPVA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Rienso 510mg/17ml solution for infusion vials
0901012Q0BBAAAA
|
Rienso | Ferumoxytol | Nutrition and Blood | No data available |
|
Rifabutin 100mg/5ml oral liquid
0501090Q0AAAZAZ
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifabutin 150mg/5ml oral liquid
0501090Q0AAAUAU
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifabutin 50mg/5ml oral liquid
0501090Q0AAAJAJ
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifabutin 60mg/5ml oral liquid
0501090Q0AAAGAG
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifabutin 75mg/5ml oral liquid
0501090Q0AAALAL
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifabutin 90mg/5ml oral liquid
0501090Q0AAAVAV
|
Rifabutin | Rifabutin | Infections | No data available |
|
Rifadin 600mg inf vials
0501090R0BBAEAD
|
Rifadin | Rifampicin | Infections | No data available |
|
Rifampicin 120mg/5ml oral liquid
0501090R0AAAMAM
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 150mg/5ml oral liquid
0501090R0AAAKAK
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 200mg/5ml oral liquid
0501090R0AAANAN
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 210mg/5ml oral liquid
0501090R0AAAUAU
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 30.5mg/5ml oral liquid
0501090R0AAAQAQ
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 300mg / Isoniazid 150mg capsules
0501090S0AAADAD
|
Rifampicin/isoniazid | Rifampicin combined preparations | Infections | No data available |
|
Rifampicin 300mg/5ml oral liquid
0501090R0AAAPAP
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 480mg/5ml oral liquid
0501090R0AAARAR
|
Rifampicin | Rifampicin | Infections | No data available |
|
Rifampicin 600mg inf vials
0501090R0AAADAD
|
Rifampicin | Rifampicin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.